Evidence map›Paper›PMID 42194940›Full record

ArticleJournal of clinical medicine2026

Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study.

Özlem Özdemir, Damla Günenç, Halil Taşkaynatan, Pınar Peker, Emir Gökhan Kahraman, Sedat Biter, Semra Paydaş, Tuğba Önder, Öztürk Ateş, Muhammed Muhiddin Er and 13 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Özlem ÖzdemirDepartment of Medical Oncology, Izmir Faculty of Medicine, University of Health Sciences, Izmir City Hospital, 35540 İzmir, Turkey.ORCID 0000-0003-2520-5953
Damla GünençDepartment of Medical Oncology, Ege University Faculty of Medicine, 35100 İzmir, Turkey.ORCID 0000-0002-7592-2021
Halil TaşkaynatanDepartment of Medical Oncology, Izmir Faculty of Medicine, University of Health Sciences, Izmir City Hospital, 35540 İzmir, Turkey.ORCID 0000-0002-3671-6540
Pınar PekerDepartment of Medical Oncology, Ege University Faculty of Medicine, 35100 İzmir, Turkey.ORCID 0009-0004-8769-1584
Emir Gökhan KahramanDepartment of Medical Oncology, Izmir Faculty of Medicine, University of Health Sciences, Izmir City Hospital, 35540 İzmir, Turkey.ORCID 0000-0001-5303-6590
Sedat BiterDepartment of Medical Oncology, Çukurova University Faculty of Medicine, 01330 Adana, Turkey.ORCID 0000-0002-1053-0668
Semra PaydaşDepartment of Medical Oncology, Çukurova University Faculty of Medicine, 01330 Adana, Turkey.ORCID 0000-0003-4642-3693
Tuğba ÖnderDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, 06200 Ankara, Turkey.
Öztürk AteşDepartment of Medical Oncology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, 06200 Ankara, Turkey.
Muhammed Muhiddin ErDepartment of Medical Oncology, Necmettin Erbakan University Meram Faculty of Medicine, 42080 Konya, Turkey.ORCID 0000-0002-0583-0295
Murat ArazDepartment of Medical Oncology, Necmettin Erbakan University Meram Faculty of Medicine, 42080 Konya, Turkey.
Ahmet Melih ArslanDepartment of Medical Oncology, Dokuz Eylül University Faculty of Medicine, 35340 İzmir, Turkey.ORCID 0000-0002-6126-4611
Hüseyin Salih SemizDepartment of Medical Oncology, Dokuz Eylül University Faculty of Medicine, 35340 İzmir, Turkey.ORCID 0000-0002-7083-8517
Nilüfer AvcıDepartment of Medical Oncology, Medicana Hospital, 16140 Bursa, Turkey.
İzzet DoğanDepartment of Medical Oncology, Acıbadem Bakırköy Hospital, 34140 İstanbul, Turkey.ORCID 0000-0003-1018-1119
Akif DoğanDepartment of Medical Oncology, Şehit Prof. Dr. İlhan Varank Training and Research Hospital, 34785 İstanbul, Turkey.ORCID 0000-0003-4275-2414
Teoman ŞakalarDepartment of Medical Oncology, Necip Fazıl City Hospital, 46050 Kahramanmaraş, Turkey.
Timur KöseDepartment of Biostatistics and Medical Informatics, Ege University, 35100 İzmir, Turkey.
Asuman ArgonDepartment of Medical Pathology, Izmir Faculty of Medicine, University of Health Sciences, Izmir City Hospital, 35540 İzmir, Turkey.
Enver İlhanDepartment of General Surgery, Izmir Faculty of Medicine, University of Health Sciences, Izmir City Hospital, 35540 İzmir, Turkey.ORCID 0000-0003-3212-9709
Başak Doğanavşargil YakutDepartment of Medical Pathology, Ege University, 35100 İzmir, Turkey.
Murat SezakDepartment of Medical Pathology, Ege University, 35100 İzmir, Turkey.
Bülent KarabulutDepartment of Medical Oncology, Acıbadem Hospital, 35330 İzmir, Turkey.ORCID 0000-0002-1949-8334

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-EGFR therapycolorectal cancerHER2predictive biomarkerprognostic factorRAS wild-type

Identifiers

PMID42194940
PMCPMC13207513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.